Diabetic foot disease in the elderly

Diabetes and Metabolism

Volumn 33, Issue SUPPL. 1, 2007, Pages

  Pataky, Z ^a   Vischer, U ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hopital de Geriatrie   (Switzerland)

Author keywords

Diabetes mellitus; Diabetic foot; Elderly; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLUCOSE;

AGE; AGING; ARTERY DISEASE; ARTICLE; CAST APPLICATION; COMORBIDITY; DEBRIDEMENT; DEVICE; DIABETIC FOOT; DIABETIC PATIENT; DYSLIPIDEMIA; FOOT AMPUTATION; FOOT MALFORMATION; FOOT ULCER; FUNCTIONAL ASSESSMENT; GAIT DISORDER; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; INFECTION; ISCHEMIA; MOBILIZATION; PERIPHERAL NEUROPATHY; PREVALENCE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SELF CARE; SHOE; SMOKING CESSATION; TREATMENT INDICATION; VISUAL IMPAIRMENT; WALKING;

AGED; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; INCIDENCE; OSTEOMYELITIS; PRESSURE; RISK FACTORS; WOUNDS AND INJURIES;

EID: 34547972060     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)80057-7     Document Type: Article

References (105)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Ho P., and Turtle P. Establishing the diagnosis. In: Sinclair A., and Finucane P. (Eds). Diabetes in old age (2001), John Wiley & Sons Ltd. 25-39
3. Wilson P., Anderson K., and Kannel W. Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med 80 5A (1986) 3-9
4. o). Manton K., Stallard E., and Liu K. Forecasts of active life expectancy: policy and fiscal implications. J Gerontol 48 (1993) 11-26
5. Muggeo M., Verlato G., Bonora E., et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 38 (1995) 318-325
6. Harris M., Flegal K., Cowie C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-524
7. Kumar S., Ashe H., Parnell L., et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 11 (1994) 480-484
8. Reiber G., Lipsky B., and Gibbons G. The burden of diabetic foot ulcers. Am J Surg 176 2A Suppl (1998) 5S-10S
9. Singh N., Armstrong D., and Lipsky B. Preventing foot ulcers in patients with diabetes. JAMA 293 (2005) 217-228
10. Pecoraro R., Reiber G., and Burgess E. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13 (1990) 513-521
11. Boulton A. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47 (2004) 1343-1353
12. Reiber G., Pecoraro R., and Koepsell T. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med 117 (1992) 97-105
13. Ramsey S., Newton K., Blough D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22 (1999) 382-387
14. Oyibo S., Jude E., Tarawneh I., et al. The effects of ulcer size and site, patie'nt's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18 (2001) 133-138
15. Apelqvist J., Larsson J., and Agardh C. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 233 (1993) 485-491
16. Armstrong D., Lavery L., and Harkless L. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21 (1998) 855-859
17. Adler A., Boyko E., Ahroni J., and Smith D. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory, neuropathy, and foot ulcers. Diabetes Care 22 (1999) 1029-1035
18. Nelson R., Gohdes D., Everhart J., et al. Lower-extremity amputations in NIDDM, 12-yr follow-up study in Pima Indians. Diabetes Care 11 (1988) 8-16
19. Lavery L., Ashry H., van Houtum W., Pugh J., Harkless L., and Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 19 (1996) 48-52
20. Margolis D., Allen-Taylor L., Hoffstad O., and Berlin J. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen 13 (2005) 230-236
21. Unwin N., and The Global Lower Extremity Amputation Study Group. Epidemiology of lower extremity amputation in centres in Europe. North America and East Asia. Br J Surg 87 (2000) 328-337
22. Morris A., McAlpine R., Steinke D., et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 21 (1998) 738-743
23. Siitonen O., Niskanen L., Laakso M., Siitonen J., and Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 16 (1993) 16-20
24. Rayman G., Krishnan S., Baker N., Wareham A., and Rayman A. Are we underestimating diabetes-related lower-extremity amputation rates?: Results and benefits of the first prospective study. Diabetes Care 27 (2004) 1892-1896
25. Carmona G., Hoffmeyer P., Herrmann F., et al. Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease. Diabetes Metab 31 (2005) 449-454
26. Cavanagh P., Lipsky B., Bradbury A., and Botek G. Treatment for diabetic foot ulcers. Lancet 366 (2005) 1725-1735
27. Peters E., Childs M., Wunderlich R., Harkless L., Armstrong D., and Lavery L. Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care 24 (2001) 1799-1804
28. Boulton A., Vileikyte L., Ragnarson-Tennvall G., and Apelqvist J. The global burden of diabetic foot disease. Lancet 366 (2005) 1719-1724
29. Hsu J. Foot problems in the elderly patient. J Am Geriatr Soc 19 (1971) 880-886
30. Karpman R. Foot problems in the geriatric patient. Clin Orthop Relat Res (1995) 59-62
31. Boulton A. The pathway to ulceration: aetiopathogenesis. In: Boulton A., Connor H., and Cavanagh P. (Eds). The foot in diabetes (2000), Wiley, Chichester 19-31
32. Melton L., and Dyck P. Clinical features of diabetic neuropathies-epidemiology. In: Dyck P. (Ed). Diabetic neuropathy (1987), WB Saunders Company, London 27-35
33. Veves S., and Boulton A. Diabetic neuropathy: the diabetologist's view. In: Horrobin D. (Ed). Treatment of diabetic neuropathy (1992), Churchill Livingstone, Edinburg 1-10
34. Dejgaard A. Pathophysiology and treatment of diabetic neuropathy. Diabet Med 15 (1998) 97-112
35. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl). Diabéte Metab 3 (1977) 97-107
36. Young M., Boulton A., MacLeod A., Williams D., and Sonksen P. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
37. Mold J., Vesely S., Keyl B., Schenk J., and Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 17 (2004) 309-318
38. Bus S., Yang Q., Wang J., Smith M., Wunderlich R., and Cavanagh P. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care 25 (2002) 1444-1450
39. Murray H., Young M., Hollis S., and Boulton A. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 13 (1996) 979-982
40. Pataky Z., Golay A., Faravel L., et al. The impact of callosities on the magnitude and duration of plantar pressure in patients with diabetes mellitus. A callus may cause 18,600 kilograms of excess plantar pressure per day. Diabetes Metab 28 (2002) 356-361
41. Bus S., Maas M., Cavanagh P., Michels R., and Levi M. Plantar fat-pad displacement in neuropathic diabetic patients with toe deformity: a magnetic resonance imaging study. Diabetes Care 27 (2004) 2376-2381
42. Brash P., Foster J., Vennart W., Anthony P., and Tooke J. Magnetic resonance imaging techniques demonstrate soft tissue damage in the diabetic foot. Diabet Med 16 (1999) 55-61
43. Ryder R., Kennedy R., Newrick P., Wilson R., Ward J., and Hardisty C. Autonomic denervation may be a prerequisite of diabetic neuropathic foot ulceration. Diabet Med 7 (1990) 726-730
44. Gilmore J., Allen J., and Hayes J. Autonomic function in neuropathic diabetic patients with foot ulceration. Diabetes Care 16 (1993) 61-67
45. Greenman R., Panasyuk S., Wang X., et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 366 (2005) 1711-1717
46. Boyko E., Ahroni J., Stensel V., Forsberg R., Davignon D., and Smith D. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 22 (1999) 1036-1042
47. Faglia E., Caravaggi C., Marchetti R., et al. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med 22 (2005) 1310-1314
48. Diehm C., Schuster A., Allenberg J., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 (2004) 95-105
49. Fowkes F., Housley E., Cawood E., Macintyre C., Ruckley C., and Prescott R. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J Epidemiol 20 (1991) 384-392
50. Meijer W., Hoes A., Rutgers D., Bots M., Hofman A., and Grobbee D. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18 (1998) 185-192
51. Adler A., Stevens R., Neil A., Stratton I., Boulton A., and Holman R. UKPDS 59: Hyperglycaemia and other potentially modifiable risk factors for peripheral vascular disease in Type 2 diabetes. Diabetes Care 25 (2002) 894-899
52. Stratton I., Adler A., Neil H., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
53. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003) 3333-3341
54. Doobay A., and Anand S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 25 (2005) 1463-1469
55. Wild S., Byrne C., Smith F., Lee A., and Fowkes F. Low anklebrachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study. Diabetes Care 29 (2006) 637-642
56. Khan N., Rahim S., Anand S., Simel D., and Panju A. Does the clinical examination predict lower extremity peripheral arterial disease?. JAMA 295 (2006) 536-546
57. Hiatt W., Marshall J., Baxter J., et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol 43 (1990) 597-606
58. Baxter G., and Polak J. Lower limb colour flow imaging: a comparison with ankle: brachial measurements and angiography. Clin Radiol 47 (1993) 91-95
59. Edmonds M., Blundell M., Morris M., Thomas E., Cotton L., and Watkins P. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 60 (1986) 763-771
60. Goebel F., and Fue'ssl H. Monckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 24 (1983) 347-350
61. Young M., Adams J., Anderson G., Boulton A., and Cavanagh P. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36 (1993) 615-621
62. Hankey G., Norman P., and Eikelboom J. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
63. Clagett G., Sobel M., Jackson M., Lip G., Tangelder M., and Verhaeghe R. Antithrombotic therapy in peripheral arterial occlusive disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 suppl (2004) 609S-626S
64. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing: TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
65. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
66. Reiber G., Vileikyte L., Boyko E., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22 (1999) 157-162
67. Reiber G., Smith D., Wallace C., et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 287 (2002) 2552-2558
68. De Berardis G., Pellegrini F., Franciosi M., et al. Are Type 2 diabetic patients offered adequate foot care? The role of physician and patient characteristics. J Diabetes Complications 19 (2005) 319-327
69. Assal J. Educating the diabetic patient: difficulties encountered by patients and health care providers. Concepts for the ideal diabetes clinic (1992), Gruyter, Berlin 73-87
70. Reiber G. Who is at risk of limb loss and what to do about it?. J Rehabil Res Dev 31 (1994) 357-362
71. Burns S., Leese G., and McMurdo M. Older people and ill fitting shoes. Postgrad Med J 78 (2002) 344-346
72. Dargis V., Pantelejeva O., Jonushaite A., Vileikyte L., and Boulton A. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 22 (1999) 1428-1431
73. Chantelau E., and Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med 11 (1994) 114-116
74. Viswanathan V., Madhavan S., Gnanasundaram S., et al. Effectiveness of different yypes of footwear Insoles for the diabetic neuropathic foot: a follow-up study. Diabetes Care 27 (2004) 474-477
75. Armstrong D., Lavery L., Holtz-Neiderer K., et al. Variability in activity may precede diabetic foot ulceration. Diabetes Care 27 (2004) 1980-1984
76. Maluf K., and Mueller M. Comparison of physical activity and cumulative plantar tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clin Biomech (Bristol, Avon) 18 (2003) 567-575
77. Jacobs A., and Appleman K. Foot-ulcer prevention in the elderly diabetic patient. Clin Geriatr Med 15 (1999) 351-369
78. Armstrong D., Lavery L., Nixon B., and Boulton A. It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 39 Suppl 2 (2004) S92-S99
79. Armstrong D., Lavery L., Wu S., and Boulton A. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: A randomized controlled trial. Diabetes Care 28 (2005) 551-554
80. Garrow A., van Schie C., and Boulton A. Efficacy of multilayered hosiery in reducing in-shoe plantar foot pressure in high-risk patients with diabetes. Diabetes Care 28 (2005) 2001-2006
81. Lavery L., Vela S., Ashry H., Lanctot D., and Athanasiou K. Novel methodology to obtain salient biomechanical characteristics of insole materials. J Am Podiatr Med Assoc 87 (1997) 266-271
82. Lavery L., Vela S., Fleischli J., Armstrong D., and Lavery D. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 20 (1997) 1706-1710
83. Armstrong D., Lavery L., Kimbriel H., Nixon B., and Boulton A. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 26 (2003) 2595-2597
84. Marcell T. Review Article: Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 58 (2003) M911-M916
85. Paddon-Jones D., Sheffield-Moore M., Urban R., et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 89 (2004) 4351-4358
86. Boyd C., Xue Q.-L., Guralnik J., and Fried L. Hospitalization and development of dependence in activities of daily living in a cohort of disabled older women: The Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 60 (2005) 888-893
87. Creditor M. Hazards of hospitalization of the elderly. Ann Intern Med 118 (1993) 219-223
88. Siu A., Penrod J., Boockvar K., Koval K., Strauss E., and Morrison R. Early ambulation after hip fracture: effects on function and mortality. Arch Intern Med 166 (2006) 766-771
89. Pataky Z., Faravel L., Da Silva J., and Assal J. A new ambulatory foot pressure device for patients with sensory impairment. A system for continuous measurement of plantar pressure and a feed-back alarm. J Biomech 33 (2000) 1135-1138
90. Femery V., Moretto P., Hespel J., Thevenon A., and Lensel G. A real-time plantar pressure feedback device for foot unloading. Arch Phys Med Rehabil 85 (2004) 1724-1728
91. Steed D., Donohoe D., Webster M., and Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 183 (1996) 61-64
92. Armstrong D., Salas P., Short B., et al. Maggot therapy in "Lower-Extremity Hospice" wound care: fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc 95 (2005) 254-257
93. Sherman R. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 26 (2003) 446-451
94. for the Promogran Diabetic Foot Ulcer S. Veves A., Sheehan P., and Pham H. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137 (2002) 822-827
95. Veves A., Falanga V., Armstrong D., and Sabolinski M. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24 (2001) 290-295
96. Wieman T., Smiell J., and Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 21 (1998) 822-827
97. Armstrong D., and Lavery L. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366 (2005) 1704-1710
98. Apelqvist J., Castenfors J., Larsson J., Stenstrom A., and Agardh C. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12 (1989) 373-378
99. Kalani M., Brismar K., Fagrell B., Ostergren J., and Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 22 (1999) 147-151
100. Wutschert R., and Bounameaux H. Predicting healing of arterial leg ulcers by means of segmental systolic pressure measurements. Vasa 27 (1998) 224-228
101. Wutschert R., and Bounameaux H. Determination of amputation level in ischemic limbs. Reappraisal of the measurement of TcPo2. Diabetes Care 20 (1997) 1315-1318
102. Rosenblum B., Pomposelli Jr. F., Giurini J., et al. Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes. A 5-year experience. Diabetes Care 17 (1994) 983-987
103. Jude E., Oyibo S., Chalmers N., and Boulton A. Peripheral Arterial Disease in Diabetic and Nondiabetic Patients: A comparison of severity and outcome. Diabetes Care 24 (2001) 1433-1437
104. Pomposelli F., Kansal N., Hamdan A., et al. A decade of experience with dorsalis pedis artery bypass: Analysis of outcome in more than 1000 cases. J Vasc Surg 37 (2003) 307-315
105. Ouriel K. Peripheral arterial disease. Lancet 358 (2001) 1257-1264